Meta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States (Q37184472)

18 August 2017

0 references

Meta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States (English)

1 reference

18 August 2017

0 references

0 references

hepatocellular carcinoma

1 reference

inferred from title

United States of America

1 reference

D Tan

1

1 reference

18 August 2017

A Yopp

2

1 reference

18 August 2017

M S Beg

3

1 reference

18 August 2017

P Gopal

4

1 reference

18 August 2017

A G Singal

5

1 reference

18 August 2017

language of work or name

English

0 references

publication date

19 August 2013

1 reference

Alimentary Pharmacology & Therapeutics

18 August 2017

1 reference

18 August 2017

38

1 reference

18 August 2017

7

1 reference

18 August 2017

703-712

1 reference

Improving hepatocellular carcinoma screening: applying lessons from colorectal cancer screening.

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Failure rates in the hepatocellular carcinoma surveillance process.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Healthcare disparities in Asians and Pacific Islanders with hepatocellular cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Presentation and outcomes of hepatocellular carcinoma patients at a western centre

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Management of hepatocellular carcinoma: An update

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

A multicenter retrospective study on clinical characteristics, treatment patterns, and outcome in elderly patients with hepatocellular carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Underutilization of therapy for hepatocellular carcinoma in the medicare population

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Rates of surveillance and management of hepatocellular carcinoma in patients evaluated at a liver transplant center

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Interfaces across the cancer continuum offer opportunities to improve the process of care

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

The interface of primary and oncology specialty care: from diagnosis through primary treatment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Toward improving the quality of cancer care: addressing the interfaces of primary and oncology-related subspecialty care

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Racial discrepancies in the outcome of patients with hepatocellular carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Some methodologic lessons learned from cancer screening research

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985-1996.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

The performance of process measures in hepatitis C.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Racial disparity and their impact on hepatocellular cancer outcomes in inner-city New Orleans

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Health insurance status affects staging and influences treatment strategies in patients with hepatocellular carcinoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail?

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Predictors of surgical intervention for hepatocellular carcinoma: race, socioeconomic status, and hospital type

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Population-based risk factors and resource utilization for HCC: US perspective

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Survival in Asian Americans after treatments for hepatocellular carcinoma: a seven-year experience at UCLA.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777750

Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FAPT.12450

Factors That Affect Risk for Hepatocellular Carcinoma and Effects of Surveillance

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FAPT.12450

Potentially curative treatment in patients with hepatocellular cancer-results from the liver cancer research network

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FAPT.12450

Inconsistency in the management of patients with hepatocellular carcinoma: the need for a strict protocol

21 January 2018

1 reference

12 December 2020

Ethnic differences in hepatocellular carcinoma: implications for liver transplantation

1 reference

12 December 2020

A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis

1 reference

12 December 2020

Influence of direct referrals on time to diagnosis after an abnormal breast screening result

1 reference

12 December 2020

Changing management and outcome of hepatocellular carcinoma: evaluation of 501 patients treated at a single comprehensive center

1 reference

12 December 2020

Identifiers

DOI

10.1111/APT.12450

1 reference

18 August 2017

1 reference

18 August 2017

1 reference